Treatment of Intractable Interstitial Lung Injury with Alemtuzumab after Lung Transplantation
- 1 June 2011
- journal article
- case report
- Published by Elsevier in Transplantation Proceedings
- Vol. 43 (5) , 1868-1870
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Alemtuzumab in the Treatment of Refractory Acute Rejection and Bronchiolitis Obliterans Syndrome After Human Lung TransplantationAmerican Journal of Transplantation, 2007
- The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantationTransplant International, 2006
- Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapyThe Journal of Thoracic and Cardiovascular Surgery, 2005
- Treatment of refractory acute rejection in a lung transplant recipient with campath 1H.Transplantation, 2002